Mr. DeLucia has over 35 years of experience in the biopharmaceutical industry including early-stage drug development, business development and management of strategic partnerships.

Mr. DeLucia is Co-Founder of Cascador, a program for mid-stage entrepreneurs in Africa who are scaling mission-driven companies. Mr. DeLucia also co-founded and was CEO of ImmuNext, an immunotherapy-based company, and CEO of MIST Inc., a breast cancer imaging company. Prior to MIST, he led the development of a drug development technology platform at Millennium Pharmaceuticals which was spun out as part of a separate company in 2003.

 He has an M.S. from MIT and a B.A. from Dartmouth College.